Propofol Overdose of Undetermined Intent Clinical Trial
Official title:
Relationship Between Pre-induction Electroencephalogram Pattern of Adult Patients and Their Sensitivity to Propofol
Verified date | October 2023 |
Source | Seoul National University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The induction dose of propofol is generally determined based on patients' characteristics, underlying disease, general condition, and also by clinician's experiences. However, It is difficult to anticipate and objectively calculate an adequate dose of propofol for every patient considering the variability of an individual's response to propofol. If there is a specific pattern in EEG prior to induction of anesthesia that can provide information about the patient's susceptibility to propofol, every induction may be performed far more smoothly with a precisely optimized dose of propofol for each patient. The study is to find a relationship between the pre-induction EEG pattern of adult patients and their sensitivity to propofol.
Status | Completed |
Enrollment | 70 |
Est. completion date | February 28, 2022 |
Est. primary completion date | February 28, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 89 Years |
Eligibility | Inclusion Criteria: - Adult patients undergoing general anesthesia Exclusion Criteria: - Patients undergoing cardiac or brain surgery - Patients with neurological deficit or impaired communication (Glasgow Coma Scale < 15) - Unstable vital sign (cardiogenic, hemorrhagic, septic shock) - Patients with eclampsia - Patients who administered preoperative anxiolytics - Patients who do not require intubation - Patients who are considered unsuitable for the study |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Seoul National University Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Absolute and Relative power in distinct frequency (% d: 1-4 Hz, % ?: 5-8 Hz, % a: 9-12 Hz, % ß: 13-25 Hz) | Relative power in distinct frequency (% d: 1-4 Hz, % ?: 5-8 Hz, % a: 9-12 Hz, % ß: 13-25 Hz) | During the induction of anesthesia (up to 15 min) | |
Primary | Processed EEG index (PSI; patient state index) | Processed EEG index (PSI; patient state index) | During the induction of anesthesia (up to 15 min) | |
Primary | Mean frequency and 95% spectral edge frequency (Hz) | Mean frequency and 95% spectral edge frequency (Hz) | During the induction of anesthesia (up to 15 min) | |
Primary | Burst suppression ratio (%) | Burst suppression ratio (%) | During the induction of anesthesia (up to 15 min) | |
Secondary | The effect-site concentrations of propofol at loss of consciousness (µg/ml) | The effect-site concentrations of propofol at loss of consciousness (µg/ml) | During the induction of anesthesia (up to 15 min) | |
Secondary | The dose of propofol required for loss of consciousness (mg) | The dose of propofol required for loss of consciousness (mg) | During the induction of anesthesia (up to 15 min) | |
Secondary | Total amount of propofol used (mg) | Total amount of propofol used (mg) | During the induction of anesthesia (up to 15 min) | |
Secondary | Time to loss of consciousness (second) | Time to loss of consciousness (second) after the start of induction | During the induction of anesthesia (up to 15 min) | |
Secondary | Vital sign - blood pressure | Check blood pressure (mmHg) | During the induction of anesthesia (up to 15 min) | |
Secondary | Vital sign - heart rate | Check heart rate (beats per minute) | During the induction of anesthesia (up to 15 min) | |
Secondary | Administration of vasopressors (ephedrine, phenylephrine, epinephrine, etc) | Administration of vasopressors (ephedrine (mg), phenylephrine (mcg), epinephrine (mcg), etc) | During the induction of anesthesia (up to 15 min) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05158426 -
Application of the Propofol Precise Infusion Model
|
||
Completed |
NCT02199522 -
Clinical Observation of Titration Induction and Convention Induction of Propofol
|
N/A | |
Completed |
NCT01435785 -
Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients
|
N/A |